Ftse Mib
34.191,79
-0,48%
DAX
19.210,81
-0,17%
S&P 500
5.870,62
-1,32%
NASDAQ
18.680,12
-2,24%
Bitcoin
91.096,95
0,04%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Adma Biologics Inc (ADMA) Adma Biologics Inc (ADMA) Notizie

Adma Biologics Inc

ADMA
19,05
-1,15 (-5,69%)
16 Nov 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
07/11/202423:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202422:10EDGAR2Form 8-K - Current report
07/11/202422:05GLOBEADMA Biologics Announces Third Quarter 2024 Financial..
31/10/202422:25EDGAR2Form 8-K - Current report
29/10/202421:10GLOBEADMA Biologics to Report Third Quarter 2024 Financial..
10/10/202415:29EDGAR2Form 8-K - Current report
09/10/202423:25EDGAR2Form 8-K - Current report
03/10/202403:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/10/202403:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/9/202413:00GLOBEADMA Biologics Set to Join S&P SmallCap 600 Index
12/9/202403:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/9/202413:00GLOBEADMA Biologics to Participate in the 2024 Cantor Global..
10/9/202403:00EDGAR2Form 144 - Report of proposed sale of securities
07/9/202400:43PRNUSPalantir Technologies, Dell Technologies, and Erie Indemnity..
31/8/202403:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/8/202403:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/8/202403:00EDGAR2Form 144 - Report of proposed sale of securities
30/8/202403:26EDGAR2Form 144 - Report of proposed sale of securities
28/8/202403:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/8/202403:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/8/202403:28EDGAR2Form 144 - Report of proposed sale of securities
14/8/202415:05EDGAR2Form 8-K - Current report
14/8/202414:59GLOBEADMA Biologics Announces Partial Paydown of Revolving Credit..
08/8/202423:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/8/202422:10EDGAR2Form 8-K - Current report
08/8/202422:05GLOBEADMA Biologics Announces Second Quarter 2024 Financial..
01/8/202413:00GLOBEADMA Biologics to Report Second Quarter 2024 Financial..
27/7/202403:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/7/202403:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/7/202403:00EDGAR2Form 3 - Initial statement of beneficial ownership of..
26/7/202423:15EDGAR2Form 8-K - Current report
15/6/202403:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202423:15EDGAR2Form 144 - Report of proposed sale of securities
04/6/202422:05EDGAR2Form 8-K - Current report
17/5/202415:00EDGAR2Form 8-K - Current report
09/5/202423:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
09/5/202422:06EDGAR2Form 8-K - Current report
09/5/202422:05GLOBEADMA Biologics Announces First Quarter 2024 Financial..
09/5/202413:47IHMARKETNEWSU.S. Index Futures Dip, Bank of England Holds Interest Rates..
02/5/202413:00GLOBEADMA Biologics to Report First Quarter 2024 Financial..
11/3/202421:05EDGAR2Form 8-K - Current report
11/3/202417:19EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
11/3/202412:00GLOBEADMA Biologics Announces FDA Approvals of Extended Room..
09/3/202403:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:05EDGAR2Form 8-K - Current report
05/3/202413:00GLOBEADMA Biologics to Participate in the Raymond James..
05/3/202403:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202403:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202403:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202403:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 20,23 Min: 19,02 Max: 20,34
Chiusura: 20,20

La tua Cronologia

NASDAQ
ADMA
Adma Biologics
NASDAQ
ICCH
ICC
BTHB
CTXCKRW
Cortex
ASX
DAVA
DFA Australia
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network